The Division of Nephrology and Hypertension, Department of Internal Medicine, FMUI/RSCM will host an annual scientific meeting, the “Jakarta Nephrology Meeting (JNM) 2024”. This meeting acts as an effort to improve the knowledge and competencies of general practitioners, internists, and nephrologists, as well as those from other related disciplines in the nephrology and hypertension fields. The JNM is being held for the sixth time this year, featuring new and updated intriguing topics.

This year’s JNM theme is “Improving Quality of Care in End-Stage Kidney Disease,” which intends to study extensively topics associated with chronic kidney disease, with a highlight in end-stage kidney disease (ESKD) and its updated standard of care. Recently, incidence rates of treated ESKD were relatively stable in many higher-income countries but rose substantially predominantly in East and Southeast Asia. The prevalence of treated ESKD has increased worldwide, likely due to improving ESKD survival, population demographic shifts, higher prevalence of ESKD risk factors, and increasing KRT access in countries with growing economies. The morbidity and mortality of ESKD patients are still high, with a mortality is around 22%. This high morbidity and mortality can be reduced significantly by performing good quality kidney replacement therapy (KRT) based on individual preference (hemodialysis/HD, continuous ambulatory peritoneal dialysis/CAPD, kidney transplant, and conservative treatment).